SMA–doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours
- 1 June 2004
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 97 (2), 219-230
- https://doi.org/10.1016/j.jconrel.2004.03.027
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (13218107)
This publication has 20 references indexed in Scilit:
- Pegylated Zinc Protoporphyrin: A Water-Soluble Heme Oxygenase Inhibitor with Tumor-Targeting CapacityBioconjugate Chemistry, 2002
- Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal TissuesJapanese Journal of Cancer Research, 1998
- Conjugation of copper-zinc superoxide dismutase with succinylated gelatin: Pharmacological activity and cell-lubricating functionBioconjugate Chemistry, 1993
- Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodolEuropean Journal Of Cancer, 1992
- Enhanced Intestinal Absorption of a Hydrophobic Polymer-Conjugated Protein Drug, Smancs, in an Oily FormulationPharmaceutical Research, 1990
- Protein Binding of Macromolecular Anticancer Agent SMANCS: Characterization of Poly(styrene-co-maleic acid) Derivatives as an Albumin Binding LigandJournal of Bioactive and Compatible Polymers, 1988
- Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological propertiesJournal of Medicinal Chemistry, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971